Chemical Compound
Urea, N-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)-; N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea; AV 951; KRN 951; Kil 8951; N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea; Tivozanib
CAS Registry Number
475108-18-0
Primary record
Urea, N-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)-; N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea; AV 951; KRN 951; Kil 8951; N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea; Tivozanib
- 库存
- 7,366 克
- 纯度
- 98.4 %
- CAS
- 475108-18-0
化合物标识与属性
- CAS
- 475108-18-0
- PubChem CID
- 9911830
- SMILES
- CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl
- Canonical SMILES
- COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC
名称与同义词
- Tivozanib
- 475108-18-0
- Tivozanib (AV-951)
- fotivda
- AV-951
- tivozanibum
- Tivozanib [USAN]
- 4ase
- KRN-951
- AV951 Tivozanib
- AV-951(Tivozanib)
- AV-951,Tivozanib
- AV951 cpd
- Tivozanib [USAN:INN]
- AV951
- KRN951
- C22H19ClN4O5
- RefChem:58429
- TIVOZANIB [INN]
- Kil-8951
- AV 951
- Tivozanib (USAN/INN)
- KIL8951
- Tivozanib - AV-951
- Tivozanib(AV-951)?
- MFCD15146788
- cc-12
- D0W7JZ
- KRN 951
- TIVOZANIB [WHO-DD]
- CHEMBL1289494
- MLS006011287
- SCHEMBL172883
- DTXSID20963865
- Tivozanib - Bio-X trade mark
- GTPL6058
- orb1305458
- AV-951;KRN951
- SCHEMBL29354238
- SCHEMBL29354604
- CHEBI:91327
- KS-00001CTN
- DTXCID60205690
- EX-A472
- L01XE34
- SYN1013
- SPMVMDHWKHCIDT-UHFFFAOYSA-N
- Tivozanib hydrochloride monohydrate
- UNII-172030934T
- GLXC-90218
- HMS3229O09
- HMS3244C19
- HMS3244C20
- HMS3244D19
- HMS3265A11
- HMS3265A12
- HMS3265B11
- HMS3265B12
- HMS3654G22
- HMS3745C05
- HMS5079O15
- AMY39975
- AOB87139
- ASP-4130
- BCP01980
- ZINC1489430
- ASP4130/AV-951
- VEGFR Tyrosine Kinase Inhibitor IV
- 1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea
- ABP001003
- AN-470
- BDBM50331095
- EBC-11349
- NSC758007
- NSC800952
- RS0093
- s1207
- AKOS022177607
- ACN-041317
- BCP9000343
- CCG-206805
- CID9911830
- CS-0103
- DB11800
- EX-8600
- KRN 951 /TIVOZANIB/AV-951
- NSC-758007
- NSC-800952
- PB28569
- SDCCGSBI-0636568.P003
- NCGC00249390-01
- NCGC00249390-05
- NCGC00249390-12
- 4CA-1259
- AC-24702
- AJ-26332
- AK-41796
- AS-16997
- BC659936
- BP-44057
- BT160380
- BT300016
- HY-10977
- SC-54549
- SMR004703037
- SY122249
- AB0007909
- 172030934T
- A2251
- FT-0700315
- N-[2-CHLORO-4-[(6,7-DIMETHOXY-4-QUINOLYL)OXY]PHENYL]-N'-(5-METHYL-3-ISOXAZOLYL)UREA
- NS00068487
- ST24037076
- SW219364-1
- X4932
- J2.121.508B
- A10101
- A24970
- D09683
- Q-3811
- 108K180
- EN300-18167318
- Q7810457
- BRD-K53414658-001-01-7
- BRD-K53414658-001-08-2
- N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]pheny
- 1-(2-CHLORO-4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-3-(5-METHYLISOXAZOL-3-YL)UREA
- 1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea
- 1-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-3-(5-methyl-1,2-oxazol-3-yl)urea
- AV951, AV-951, 475108-18-0
- B2693-413727
- Urea, N-(2-chloro-4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)-
- Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor IV
- 1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)-oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea
- 1-[2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-3-(5-methylisoxazol-3-yl)urea
- N-(2-Chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N′-(5-methyl-3-isoxazolyl)urea
- N-(2-Chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)urea
- 682745-41-1
- 1-(2-chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methyl-1,2-oxazol-3-yl)urea
- 1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxy-phenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea
- 1-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-3-(5-methyl-3-isoxazolyl)urea
- 1-[2-Chloro-4-[(6,7-dimethoxyquinoline)-4-yloxy]phenyl]-3-(5-methylisoxazole-3-yl)urea
- N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea
- N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea
- 1-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-3-[(3E)-5-methylisoxazol-3(2H)-ylidene]urea
- 968-821-5
- AV9
- N-(2-CHLORO-4-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PHENYL)-N'-(5-METHYLISOXAZOL-3-YL)UREA
- N-{2-Chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(5-methyl-1,2-oxazol-3-yl)urea
- Urea, N-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)-; N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea; AV 951; KRN 951; Kil 8951; N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea; Tivozanib